Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

IMCAS and TB Alliance will Search TCM for TB Drug

publication date: Apr 3, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

A new partnership has been established that will investigate traditional Chinese medicines for a new, more effective treatment of tuberculosis. The Institute of Microbiology (IMCAS), a member institute of the Chinese Academy of Sciences, will team up with the Global Alliance for TB Drug Development (TB Alliance) to do the work. IMCAS, which is located in Beijing, has completed a pilot screen that identified 24 natural product extracts as having potential anti-tubercular activity. IMCAS and the TB Alliance will collaborate to test these extracts further. More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors